B5FG53 AF NFT

Methionine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifyy376cb4icrp42nw5rqva3t46tvj5rhcl4mjde76b6qcofxdena/metadata.json
IPFS of structure file: 
bafybeih6e6wamgioirtyyawhujzetfqnyvvleq54d6pbwiiinh2vu65ali/AF-B5FG53-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x80D2ac0F5e3268bC5C1d28BBAA07E3169BB02b79
First NFT owner address (bech32): 
genesis1srf2cr67xf5tchqa9za65plrz6dmq2me66p797
Current NFT ID #450615 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
450615
Accession (UniProt):
B5FG53
Name::
Methionine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Aliivibrio fischeri (strain MJ11)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B5FG53 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B5FG53|SYM_ALIFM Methionine--tRNA ligase OS=Aliivibrio fischeri (strain MJ11) OX=388396 GN=metG PE=3 SV=1 MATDPRKILVTCALPYANGSIHLGHMLEHIQADIWVRYQRLRGNDVNFICADDAHGTPIMLKAQQMGISPEEMIAAVSEEHQKDFAGFDISFDNYHSTHSDENRELASHIYLELKKNGFITSRTISQLFDPEKEMFLPDRFVKGTCPKCKAEEQYGDNCDNCGETYSPTDLINPKSAVSGATPVMKDSEHFFFDLPQFESMLKEWTRSGSLQTETANKMQEWFESGLQQWDISRDAPYFGFEIPGETNKFFYVWLDAPIGYMGSFKNLCNKRDDLNFDEYWKKDSTTELYHFIGKDIVYFHSLFWPAMLDGAGFRKPNNVFVHGYVTVNGAKMSKSKGTFIKAGTYLNHLDPECLRYYYAAKLNSRIDDLDLNLEDFTQRVNSDVVNKIVNLASRNAGFITKRFDGKLADNFAEPELYNEFIAAADRIAELYETREFGRAIREITALADKANQYIDEKAPWVLAKEEGKEQELQEVSSVGINLFRVLMAYLKPVMPELAARTEAFLNETLTWEGVAQPLVAHEITKFKALFARIDPKKVEAMIEESKEDAAIEMAAKEKAEAEKEKASQTELDKDPIADEIEFDAFEAVDMRIARIISCEEVPKANKLLKFQLDIGGETRQVFSGIKSAYKPEELEGKLTVMVANLKPRKMKFGMSEGMILAAGPGGKDLWILEPHEGAQPGMRVM